Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI - Wikidata - awgldk - TriplyDB

Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

http://www.wikidata.org/entity/Q28169027

about

Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

http://www.wikidata.org/entity/Q28169027

description

2004 nî lūn-bûn

@nan

2004 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մարտին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

@ast

Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

@en

Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

@nl

type

label

Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

@ast

Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

@en

Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

@nl

prefLabel

Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

@ast

Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

@en

Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

@nl

P1433

Q28169027-5F789CDA-C28A-47F6-BEDB-78E3A9465E44

P1476

Q28169027-00C14F86-D454-4EF2-8D88-56AB28CBFEB4

P2093

Q28169027-16D87C4D-BF19-4105-B094-D565D57F7D7C

Q28169027-9CF8AD1F-BFEB-4B97-BA92-2E63B216D87B

P2860

Q28169027-6D19EB50-D723-4192-981B-DA4DDA0323E7

Q28169027-748A6919-D26E-4A36-B024-0BED65E14418

Q28169027-B4064EB2-8D5B-48CB-B2E1-E20AEA11103D

Q28169027-D64B5D81-7A13-4B9B-8FF4-1DA4FD136108

Q28169027-E343B307-2F23-4780-990C-B99820E4C71E

Q28169027-EAFFA2D0-FA74-4E35-A378-E229B95AC179

Q28169027-EF82583F-CB12-48D2-92E9-692147EA1EC6

Q28169027-EFBAB3FD-9FDE-4452-8D49-5967BFDD1C09

Q28169027-FF72EB94-CE48-447E-BC82-4D04B06952D3

P304

Q28169027-362AD21B-02FC-4D83-9A9B-412110F5B1CA

P31

Q28169027-8BE03A92-3736-458E-B4B9-A18E2DF359E5

P356

Q28169027-3831998E-7E68-44AE-87C1-BC4069131F39

P407

Q28169027-D37C3F8B-8591-41C9-90A0-530D4D5193F3

P433

Q28169027-4B35CDC7-48BA-4DB4-B944-531B17C21423

P478

Q28169027-65BBF844-D019-4057-A108-FE417E25FB9B

P577

Q28169027-F56E8302-513A-41FD-8D8B-DB0F2555FF4F

P698

Q28169027-2A69121E-02FC-49A7-9E56-FC92541BC9F2

P356

14017430310016199

P1433

Scandinavian Cardiovascular Journal

P1476

Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

@en

P2093

Frank Brosstad

http://www.w3.org/2001/XMLSchema#string

Jan Erik Otterstad

http://www.w3.org/2001/XMLSchema#string

P2860

Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin

Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial.

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes.

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

P304

9-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14017430310016199

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15204241

http://www.w3.org/2001/XMLSchema#string